Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Baxter
 More »

  • Vivaldi Buys Flu Vaccine R&D Assets from Baxter
    Vivaldi Biosciences said today it acquired from Baxter R&D assets-including intellectual ... preparedness and seasonal influenza. Vivaldi Buys Flu Vaccine R&D Assets from Baxter
    10-10-2013
  • Young Companies in the Money: 25 Firms to Watch
    ... Venture Fund, and Seroba Kernel Life Sciences; and new investors Sunstone Capital, Baxter Ventures, Amgen Ventures, and EMBL Ventures #14. Effector Therapeutics Amount: $45 ...
    10-2-2013
  • Tips for Working Optimally with CMOs
    Contract manufacturing has experienced several notable twists and turns over the last two decades. Particularly in biopharmaceuticals, the distinction between development and ...
    10-1-2013
  • Baxter, Coherus Ink Biosimilar Collaboration Worth Up to $246M
    Baxter International and Coherus Biosciences said today they will develop and ... Baxter expects the exclusive collaboration-projected by the companies to generate up to ...
    9-3-2013
  • What the Top 15 Biopharma CEOs Are Making
    proxy filings with the SEC, Baxter International Chairman and CEO Robert L. Parkinson finished 2012 with $17,521,770 in total compensation, up 24.6% from the previous year. ...
    7-31-2013
  • Top 15 Job-Cutting Companies of 2013 (So Far)
    and manufacturing positions (Novartis, Baxter, Impax, and to a lesser extent ... results disclosed April 25. #5. Baxter International Number of job layoffs ...
    7-11-2013
  • Biogen Idec, Sobi Cite Promising Phase III Results for Hemophilia...
    At ISTH, Baxter presented data showing Advate's effect on "peaks" when patients had the ... design individual dosing regimens to reduce bleed frequency, Baxter said in a statement. ...
    7-5-2013
  • FDA Approves Baxter's Rixubis for Hemophilia B
    has approved Baxter International's Rixubis for use in hemophilia B patients 16 and up. ... In a Baxter statement, Val Bias, chief executive officer of the National Hemophilia ...
    7-1-2013
  • Biopharma Layoffs: Relocate or Not?
    have prompted drug and diagnostics companies to step up job reductions. Eli Lilly, Baxter International, Bristol-Myers Squibb, Novartis, and Roche are among the pharma ...
    6-19-2013
  • Caution: Falling Job Zone
    Pharma giants disclosing job cuts in 2013 through June 13 include Eli Lilly (1,000 sales reps), Baxter International (400 in Puerto Rico), Bristol-Myers Squibb (about 400 in San ...
    6-14-2013
  • Top 20 Corporate Venture Funds
    ... or diagnostics; North American and European regions Year established: 2001 #5. (tie) Baxter Ventures Resources: $200 million Current portfolio: Seven investments, most being ...
    6-14-2013
  • Seeking New Tools Against Alzheimer's
    May, when Baxter International's Gammagard failed in Phase III to reduce cognitive decline or preserve functional ability in mild-to-moderate Alzheimer's patients. Baxter did point ...
    6-7-2013
  • Vaccine Advances Drive Differentiation
    ... In November 2012, Novartis' Flucelvax® became the first mammalian cell-based flu vaccine approved by the FDA. GSK, Astellas, Sanofi, Baxter International, and AstraZeneca also are ...
    6-1-2013
  • Alzheimer's Research
    Baxter International's drug candidate Gammagard is the latest Alzheimer's therapeutic to fail in meeting its clinical endpoints. A number of other potential therapies have suffered ...
    5-7-2013
  • Another Alzheimer's Drug Fails Phase III Trial
    Baxter International acknowledged today that its Phase III drug candidate Gammagard ... According to topline results released by Baxter, patients with mild to moderate ...
    5-7-2013
  • More »

    Journal Articles

  • Corporate Profile: Baxter, Sustaining health and the environment...

    Sustainability: The Journal of Record
    Corporate Profile: Baxter, Sustaining health and the environment at a global medical products and services company Sustainability: The Journal of Record
  • Impact of Leukapheresis Cell Composition on Immunomagnetic Cell...
    C. Perotti, C. Del Fante, G.L. Viarengo, P. Bergamaschi, C. Tinelli, L. Bellotti, A. Marchesi, C. Parisi, L. Salvaneschi
    Stem Cells and Development
    Impact of Leukapheresis Cell Composition on Immunomagnetic Cell Selection with the Baxter ... A total of 39 consecutive CD34+ ICS were performed with the Isolex 300i (Baxter) device on ...
  • In Memoriam John D. Baxter, M.D., 1940-2011
    Thomas S. Scanlan, Robert J. Fletterick
    Thyroid
    In Memoriam John D. Baxter, M.D., 1940-2011 Thyroid
  • Comparative Evaluation of Procedures with a Baxter CS-3000 Cell...
    Atsushi Makimoto, Yoshifumi Kawano, Takanori Abe, Yasuhiro Okamoto, Junko Sato, Ryuji Nakagawa, Hiroyoshi Watanabe, Tsutomu Watanabe, Yasuhiro Kuroda, Lisa Sweet, Yoichi Takaue
    Stem Cells and Development
    Comparative Evaluation of Procedures with a Baxter CS-3000 Cell Separator for Collecting Peripheral Blood Cells from Children Stem Cells and Development

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll